Filing Details
- Accession Number:
- 0000719135-23-000040
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-06-29 16:42:04
- Reporting Period:
- 2023-06-26
- Accepted Time:
- 2023-06-29 16:42:04
- Original Submission Date:
- 2023-06-28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 719135 | Apyx Medical Corp | APYX | Surgical & Medical Instruments & Apparatus (3841) | 112644611 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1764505 | Todd Hornsby | C/O Apyx Medical Corporation 5115 Ulmerton Road Clearwater FL 33760 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-26 | 15,000 | $1.77 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-26 | 15,000 | $7.56 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Option to Buy) | Disposition | 2023-06-26 | 15,000 | $0.00 | 15,000 | $1.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2019-12-18 | 2025-12-17 | No | 4 | M | Direct |
Footnotes
- The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023
- This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions
Billionaire Hedge Funds
